Key Players
Competitive Landscape
Key Players
Haleon plc, dsm-firmenich, Nestle (Nature's Bounty and mainstream supplements), Pharmavite LLC (Nature Made), Bayer Consumer Health, Amway (Nutrilite), BASF SE are covered in the competitive discussion.
Table 7: Company Developments and Commercial Implications
| Evidence | Commercial effect | Buyer action |
|---|---|---|
| Nestle agrees to sell Nature's Bounty and mainstream supplements for USD 1.0 billion, 1 September 2026 | A brand portfolio with USD 1.2 billion of 2025 sales moves to a private equity owner. Closing is expected in the first half of 2027 and needs regulatory approvals. | Retail buyers should review trade terms and promotional plans with the incoming owner. |
| dsm-firmenich launches Biond pharmaceutical-grade vitamins for biologics manufacturing, 29 September 2026 | Vitamins for cell culture media are sold through one distribution channel, the BYPHAR range of Brenntag Pharma. | Biopharma buyers should qualify supply and technical support through that channel. |
| Amway commissions solid dose tablet manufacturing at its Nutrilite plant in Michigan, 6 May 2026 | A USD 75 million investment supports 877 Nutrilite SKUs across 136 formulas in 60 markets. | Ingredient suppliers should confirm tablet specifications and volumes with Amway. |
How are the companies positioned?
Haleon, Bayer, Pharmavite and Amway sell branded finished products. dsm-firmenich and BASF supply vitamin ingredients. Nestle is selling its mainstream brands.
What matters when a buyer qualifies a vitamin supplier?
Buyers check supply security, price formula and quality records. A July 2024 fire at the isophytol plant of BASF cut vitamin A and vitamin E volumes. Bayer says it pays more for audit-ready supply with a qualified second source.
Which capabilities distinguish the product offers?
Clinical evidence, personalised packs and new formats separate leading brands. Haleon's Centrum Daily Kits offer 30-day personalised packs, while Bayer wants clinical evidence on the finished product.
How does geographic reach affect competition?
Haleon's total Asia-Pacific revenue grew 5.2% to GBP 2.6 billion in 2025. Its supplement growth there came from launches in China, South Korea and the Philippines.
Representative Company Overview
Table 8: Vitamin and Mineral Market Representative Company Overview
| Company | Positioning | Verified activity |
|---|---|---|
| Haleon plc | Consumer health group with Centrum, Caltrate and Emergen-C | Vitamins, minerals and supplements revenue of GBP 1.7 billion in 2025, up 1.9%. Launched Centrum Age Defy in the United States in the first half of 2026. |
| dsm-firmenich | Vitamin and nutrient ingredient supplier | Health, Nutrition and Care sales of EUR 2,102 million in 2025. Launched Biond pharmaceutical-grade vitamins on 29 September 2026. |
| Nestle (Nature's Bounty and mainstream supplements) | Owner of mainstream supplement brands now being sold | Agreed on 1 September 2026 to sell mainstream brands with USD 1.2 billion of 2025 sales for USD 1.0 billion. Regulatory approvals are pending. |
| Pharmavite LLC (Nature Made) | Maker of Nature Made vitamins, minerals and gummies | Opened a USD 250 million gummy plant in Ohio in spring 2025 with capacity of three billion gummies a year. |
| Bayer Consumer Health | Branded nutritionals including Berocca, Redoxon, Elevit and Supradyn | Says it wants health span products and does not want to launch traditional multivitamins. Aims to reach 50 million people a year with vitamins and minerals by 2030. |
| Amway (Nutrilite) | Direct-selling supplement brand owner | Total sales of USD 7.3 billion in 2025, down 1.0%. Commissioned solid dose tablet manufacturing in Michigan in May 2026. |
| BASF SE | Vitamin A, vitamin E and carotenoid ingredient producer | Nutrition & Health division sales of EUR 1,744 million in 2025, down 11.8%, after a July 2024 isophytol plant fire. |
Research Methodology
The vitamin and mineral market assessment was conducted using primary interviews and secondary literature analysis combined with top-down data triangulation to validate market size, segment shares, and competitive positioning.